Keros Therapeutics Cash Flow Statement 2019-2024 | KROS

Fifteen years of historical annual cash flow statements for Keros Therapeutics (KROS).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-152.99$-104.68$-58.74$-45.36$-12.34
$0.82$0.67$0.38$0.28$0.21
$30.32$19.64$12.29$5.91$2.85
$31.13$20.31$12.67$6.19$3.06
$-0.14$18.00$-18.00$0$0
$0$0$0$0$0
$1.61$-0.41$1.49$0.06$1.31
$-9.38$-8.61$-2.21$-0.38$-9.23
$-2.65$14.31$-16.07$2.28$-6.72
$-124.51$-70.06$-62.15$-36.89$-16.00
$-2.46$-1.24$-1.02$-0.29$-0.27
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-2.46$-1.24$-1.02$-0.29$-0.27
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$179$120$28.55$243$0.01
$179$120$28.55$299$0.01
$0$0$0$0$0
$-0.09$-0.09$0$-3.20$0
$179$120$28.55$296$0.01
$51.98$49.01$-34.62$259$-16.26
$28.76$18.68$11.72$4.10$0.06
$0$0$0$0$0